Lijun International Pharmaceutical (holding) Co., Ltd. (2005) - Financial And Strategic Analysis

Share:    

Lijun International Pharmaceutical (Holding) Co.

, Ltd. (2005) - Financial and Strategic Analysis Review

Lijun International Pharmaceutical (Holding) Co., Ltd. (Lijun) is engaged in the research, development, manufacture and marketing of a broad range of finished medicines and bulk pharmaceutical products. Its also produces antibiotics, intravenous infusion solution, non-antibiotics finished products, bulk pharmaceuticals and health care products. It operates through two major businesses, Shijiazhuang No.4 Pharmaceutical Co., Ltd., a medicine manufacturer in China and Xi'an Lijun Pharmaceutical Co., Ltd., manufacturer of antibiotics. Its manufacturing plants are located in Hebei Province and Shaanxi Province, the Peoples Republic of China. The company is headquartered in Wan Chai, Hong Kong

This comprehensive SWOT profile of Lijun International Pharmaceutical (Holding) Co., Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Lijun International Pharmaceutical (Holding) Co., Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please visit :

http://www.aarkstore.com/reports/Lijun-International-Pharmaceutical-Holding-Co-Ltd-2005-Financial-and-Strategic-Analysis-Review-51881.html

by: Aarkstore Enterprise

POST COMMENT

China Shineway Pharmaceutical Group Limited (2877) - Financial And Strategic Analysis Review Gain More By Becoming A Wholesale Dvd Retailer Zhejiang Conba Pharmaceutical Co Ltd 600572 Financial And Strategic Analysis Review --- Aarkstore Shanghai Fosun Pharmaceutical (group) Co., Ltd. (600196) - Financial And Strategic Analysis Review Wholesale Popularity Coach Poppy Guilin Sanjin Pharmaceutical Co., Ltd. (2275) - Financial And Strategic Analysis Review -- Aarkstore Zdravlje A.d. Leskovac (zdrv) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial And Strategic Analysis Review Sanofi-aventis Pakistan Limited (sapl) - Financial And Strategic Analysis Review --- Aarkstore Vetoquinol S A (veto) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise-taiko Pharmaceutical Co.,ltd. (4574) - Financial And Strategic Analysis Review Shandong Lukang International Trading Co., Ltd (600789) - Financial And Strategic Analysis Review Vital Pharmaceutical Holdings Limited (1164) - Financial And Strategic Analysis Review --- Aarkstore